RCM
Radnor Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
27,090
+3,020
| +13% | +$236K | 0.34% | 77 |
|
|
2025
Q1 | $1.75M | Buy |
24,070
+2,400
| +11% | +$174K | 0.29% | 91 |
|
|
2024
Q4 | $1.6M | Sell |
21,670
-2,114
| -9% | -$156K | 0.27% | 98 |
|
|
2024
Q3 | $1.57M | Buy |
23,784
+18,600
| +359% | +$1.23M | 0.23% | 114 |
|
|
2024
Q2 | $479K | Hold |
5,184
| – | – | 0.15% | 113 |
|
|
2024
Q1 | $495K | Hold |
5,184
| – | – | 0.08% | 220 |
|
|
2023
Q4 | $395K | Sell |
5,184
-600
| -10% | -$45.7K | 0.07% | 240 |
|
|
2023
Q3 | $401K | Hold |
5,784
| – | – | 0.08% | 234 |
|
|
2023
Q2 | $546K | Buy |
+5,784
| New | +$546K | 0.23% | 83 |
|